Literature DB >> 1319455

A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: a possible role for CRH-binding protein.

P W Saphier1, M Faria, A Grossman, D H Coy, G M Besser, B Hodson, M Parkes, E A Linton, P J Lowry.   

Abstract

A specific binding protein for human corticotrophin-releasing hormone (hCRH), which does not bind to the ovine hormone (oCRH), has recently been demonstrated in human plasma. No such binding protein has been found in sheep plasma. We have investigated the half-life of human and ovine CRH in man and in sheep. Peptides were measured directly in plasma with two-site immunoradiometric assays, as these assays are unaffected by the presence of inactivated peptide fragments. In man, the half-life of hCRH (30.5 +/- 3.3 min; mean +/- S.E.M.) was significantly (P less than 0.001) less than that of oCRH (42.8 +/- 6.4 min). In sheep, there was no significant difference between the half-life of hCRH (46.5 +/- 7.2 min) and that of oCRH (39.8 +/- 10.1 min); these half-lives were also significantly (P less than 0.001) longer than that of hCRH in man. One possible explanation for the shorter half-life of hCRH in man is that the clearance of hCRH is enhanced by CRH-binding protein, although other binding proteins often have the opposite effect. Peak ACTH and cortisol responses occurred earlier in sheep than in man, although no differences were found in the response times to oCRH or hCRH within either species. The responses were more sustained in sheep than in man, and the previously reported biphasic response was only seen in some of the sheep and not in man. Absolute responses to either peptide were greater in sheep than in man; however, in man an 8.1-fold rise in ACTH was measured in response to oCRH, while hCRH gave a significantly (P = 0.043) smaller 4.4-fold response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319455     DOI: 10.1677/joe.0.1330487

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.

Authors:  M Schafer; S A Mousa; Q Zhang; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats.

Authors:  U Freo; C Ori; S R B Weiss; G I Perini
Journal:  J Neural Transm (Vienna)       Date:  2005-04-22       Impact factor: 3.575

3.  Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides.

Authors:  Sobia Kauser; Andrzej Slominski; Edward T Wei; Desmond J Tobin
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

4.  Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1.

Authors:  Mark O Huising; Joan M Vaughan; Shaili H Shah; Katherine L Grillot; Cynthia J Donaldson; Jean Rivier; Gert Flik; Wylie W Vale
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

5.  CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface.

Authors:  Paula G Slater; Cledi A Cerda; Luis A Pereira; María E Andrés; Katia Gysling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

6.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

7.  Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 Receptor.

Authors:  Paula G Slater; Sebastian E Gutierrez-Maldonado; Katia Gysling; Carlos F Lagos
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

8.  Corticotropin-releasing hormone (CRH) alters mitochondrial morphology and function by activating the NF-kB-DRP1 axis in hippocampal neurons.

Authors:  Chiara R Battaglia; Silvia Cursano; Enrico Calzia; Alberto Catanese; Tobias M Boeckers
Journal:  Cell Death Dis       Date:  2020-11-23       Impact factor: 8.469

9.  A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks.

Authors:  Omer Karin; Moriya Raz; Avichai Tendler; Alon Bar; Yael Korem Kohanim; Tomer Milo; Uri Alon
Journal:  Mol Syst Biol       Date:  2020-07       Impact factor: 11.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.